| pubmed-article:17211270 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17211270 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:17211270 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:17211270 | lifeskim:mentions | umls-concept:C0001074 | lld:lifeskim |
| pubmed-article:17211270 | lifeskim:mentions | umls-concept:C0151937 | lld:lifeskim |
| pubmed-article:17211270 | lifeskim:mentions | umls-concept:C0206461 | lld:lifeskim |
| pubmed-article:17211270 | lifeskim:mentions | umls-concept:C0599724 | lld:lifeskim |
| pubmed-article:17211270 | lifeskim:mentions | umls-concept:C0439590 | lld:lifeskim |
| pubmed-article:17211270 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17211270 | pubmed:dateCreated | 2007-1-9 | lld:pubmed |
| pubmed-article:17211270 | pubmed:abstractText | Prophylaxis against thromboembolic complications has become routine after major orthopedic surgery. In contrast, it remains an issue for debate whether prophylaxis after minor surgery and immobilization is necessary, even though these treatments are well-known risk factors for deep-vein thrombosis (DVT). The objective of this study was to evaluate the efficacy of dalteparin during lower-limb immobilization after surgical treatment of Achilles tendon rupture. DESIGN SETTING, AND PATIENTS: Randomized, placebo-controlled, double-blind study of 105 consecutive patients surgically treated for Achilles tendon rupture in a trauma hospital. DVT screening with color duplex sonography was conducted 3 weeks and 6 weeks after surgery. All DVTs were confirmed with phlebography. Intervention was placebo or dalteparin (5000 U) given subcutaneously once daily for 6 weeks postoperatively. | lld:pubmed |
| pubmed-article:17211270 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17211270 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17211270 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17211270 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17211270 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17211270 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17211270 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:17211270 | pubmed:issn | 0890-5339 | lld:pubmed |
| pubmed-article:17211270 | pubmed:author | pubmed-author:ElvinAndersA | lld:pubmed |
| pubmed-article:17211270 | pubmed:author | pubmed-author:PonzerSariS | lld:pubmed |
| pubmed-article:17211270 | pubmed:author | pubmed-author:LärfarsGerdG | lld:pubmed |
| pubmed-article:17211270 | pubmed:author | pubmed-author:RosforsStefan... | lld:pubmed |
| pubmed-article:17211270 | pubmed:author | pubmed-author:LapidusLasse... | lld:pubmed |
| pubmed-article:17211270 | pubmed:author | pubmed-author:LevanderCatha... | lld:pubmed |
| pubmed-article:17211270 | pubmed:author | pubmed-author:de BriEdinE | lld:pubmed |
| pubmed-article:17211270 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17211270 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:17211270 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17211270 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17211270 | pubmed:pagination | 52-7 | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:meshHeading | pubmed-meshheading:17211270... | lld:pubmed |
| pubmed-article:17211270 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17211270 | pubmed:articleTitle | Prolonged thromboprophylaxis with dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo-controlled study. | lld:pubmed |
| pubmed-article:17211270 | pubmed:affiliation | Department of Orthopaedics, Karolinska Institutet at Södersjukhuset Hospital, Stockholm, Sweden. lasse.lapidus@sodersjukhuset.se | lld:pubmed |
| pubmed-article:17211270 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17211270 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17211270 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17211270 | lld:pubmed |
